Skip to content
AnalystLens
Back to TEVAIncome Statement

Teva Pharmaceutical Industries Gross Profit 2007-2026 | TEVA

Annual FY2007–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$8.94B

+10.8%YoY vs FY2024Source: 10-KFY2025

From $4.88B in FY2007 to $8.94B in FY2025: 1.8× in 18 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$2.0B+5.1%$2.2B+2.4%$2.4B+5.9%Not reported
FY25$1.9B+6.0%$2.1B+3.9%$2.3B+7.3%$2.7B+25.2%
FY24$1.8B+11.9%$2.0B+12.7%$2.1B+16.0%$2.1B−12.2%
FY23$1.6B−9.1%$1.8B+0.1%$1.9B+10.9%$2.4B+36.5%
FY22$1.7B−7.3%$1.8B−4.2%$1.7B−7.0%$1.8B−13.6%
Share24%24%25%27%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+3.0%

FY2020
$7.73B
FY2025
$8.94B

5 years selected · on the chart

01—History

Gross Profit History

Year-over-year comparison from 10-K annual reports

  19. $8.94B
YoY changeLargest recent move−21.8%in FY18Latest +10.8%

02—Ledger

Gross Profit, period by period

PeriodValueChangeSource
FY2025$8.94B+10.8%10-K
FY2024$8.06B+5.5%10-K
FY2023$7.64B+9.6%10-K
FY2022$6.97B−8.2%10-K
FY2021$7.59B−1.7%10-K
FY2020$7.73B+2.5%10-K
FY2019$7.54B−9.1%10-K
FY2018$8.30B−21.8%10-K
FY2017$10.62B−8.9%10-K
FY2016$11.65B+2.6%10-K
FY2015$11.36B+2.7%10-K
FY2014$11.06B+3.3%10-K
FY2013$10.71B+0.5%10-K
FY2012$10.65B+11.9%10-K
FY2011$9.52B+5.0%10-K
FY2010$9.06B+23.0%10-K
FY2009$7.37B+23.4%10-K
FY2008$5.97B+22.4%10-K
FY2007$4.88B—10-K

03—Questions

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is Teva Pharmaceutical Industries's current gross profit?

Teva Pharmaceutical Industries (TEVA) annual gross profit for 2025 was $8.94B, a 10.84% increase from 2024. Teva Pharmaceutical Industries gross profit for the quarter ending September 30, 2026 was $2.44B.

What was Teva Pharmaceutical Industries's gross profit in 2024?

Teva Pharmaceutical Industries annual gross profit for 2024 was $8.06B, a 5.48% increase from 2023.

What was Teva Pharmaceutical Industries's gross profit in 2023?

Teva Pharmaceutical Industries annual gross profit for 2023 was $7.64B, a 9.64% increase from 2022.

What is Teva Pharmaceutical Industries's 5-year gross profit CAGR?

Teva Pharmaceutical Industries gross profit grew at a compound annual growth rate (CAGR) of 2.96% from FY2020 to FY2025, going from $7.73B to $8.94B over 5 years.

Company
Teva Pharmaceutical Industries
Ticker
TEVA
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →